Recent advances in the application of antibodies as therapeutics.

Roberta E. Burden; Jill Caswell; Francois Fay; Christopher J. Scott

doi:10.4155/fmc.11.165

Recent advances in the application of antibodies as therapeutics.

Roberta E. Burden, Jill Caswell, Francois Fay, Christopher J. Scott

Research output: Contribution to journal › Review article › peer-review

7 Citations (Scopus)

Abstract

The application of antibodies as therapeutic agents in the treatment of cancer now represents a significant proportion of the oncology drug arena. Despite this success, the ability to engineer and exploit antibodies in many different formats is ensuring that new avenues for their therapeutic application are constantly being examined. This review examines a selection of novel antibody-based therapeutic strategies that are currently in late preclinical and clinical evaluation.

Original language	English
Pages (from-to)	73-86
Number of pages	14
Journal	FUTURE MEDICINAL CHEMISTRY
Volume	4
Issue number	1
Early online date	15 Dec 2011
DOIs	https://doi.org/10.4155/fmc.11.165
Publication status	Published - Jan 2012

ASJC Scopus subject areas

Drug Discovery
Pharmacology
Molecular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4155/fmc.11.165Licence: Unspecified

Cite this

@article{762e5b953152429194e140fca5925529,

title = "Recent advances in the application of antibodies as therapeutics.",

abstract = "The application of antibodies as therapeutic agents in the treatment of cancer now represents a significant proportion of the oncology drug arena. Despite this success, the ability to engineer and exploit antibodies in many different formats is ensuring that new avenues for their therapeutic application are constantly being examined. This review examines a selection of novel antibody-based therapeutic strategies that are currently in late preclinical and clinical evaluation.",

author = "Burden, {Roberta E.} and Jill Caswell and Francois Fay and Scott, {Christopher J.}",

year = "2012",

month = jan,

doi = "10.4155/fmc.11.165",

language = "English",

volume = "4",

pages = "73--86",

journal = "FUTURE MEDICINAL CHEMISTRY",

issn = "1756-8927",

publisher = "Future Science",

number = "1",

}

TY - JOUR

T1 - Recent advances in the application of antibodies as therapeutics.

AU - Burden, Roberta E.

AU - Caswell, Jill

AU - Fay, Francois

AU - Scott, Christopher J.

PY - 2012/1

Y1 - 2012/1

N2 - The application of antibodies as therapeutic agents in the treatment of cancer now represents a significant proportion of the oncology drug arena. Despite this success, the ability to engineer and exploit antibodies in many different formats is ensuring that new avenues for their therapeutic application are constantly being examined. This review examines a selection of novel antibody-based therapeutic strategies that are currently in late preclinical and clinical evaluation.

AB - The application of antibodies as therapeutic agents in the treatment of cancer now represents a significant proportion of the oncology drug arena. Despite this success, the ability to engineer and exploit antibodies in many different formats is ensuring that new avenues for their therapeutic application are constantly being examined. This review examines a selection of novel antibody-based therapeutic strategies that are currently in late preclinical and clinical evaluation.

U2 - 10.4155/fmc.11.165

DO - 10.4155/fmc.11.165

M3 - Review article

C2 - 22168165

SN - 1756-8927

VL - 4

SP - 73

EP - 86

JO - FUTURE MEDICINAL CHEMISTRY

JF - FUTURE MEDICINAL CHEMISTRY

IS - 1

ER -

Recent advances in the application of antibodies as therapeutics.

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this